Thyroid stimulating hormone levels rise after assisted reproductive technology

Journal of Assisted Reproduction and Genetics

Volumn 30, Issue 10, 2013, Pages 1347-1352

  Reinblatt, Shauna ^a   Herrero, Belen ^a   Correa, José A ^b   Shalom Paz, Einat ^c   Ata, Baris ^d   Wiser, Amir ^e   Morris, David ^a   Holzer, Hananel ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c HILLEL YAFFE MEDICAL CENTER   (Israel)

^d ULUDAG UNIVERSITY   (Turkey)

^e Dept Obstet Gynecol Wolfson M   (Israel)

Author keywords

Assisted reproductive technology; Estradiol; Ovarian hyperstimulation; Thyroid function; Thyroid stimulating hormone

Indexed keywords

ESTRADIOL; THYROID ANTIBODY; THYROTROPIN;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; EMBRYO TRANSFER; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; OVARIAN RESERVE; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; FEMALE; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PROSPECTIVE STUDIES; REPRODUCTIVE TECHNIQUES, ASSISTED; THYROTROPIN;

EID: 84887999940     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-013-0081-3     Document Type: Article

References (30)

1. Abalovich M, Gutierrez S, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002;12(1):63-8.
2. Alexander EK, Marqusee E, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 2004;351(3):241-9.
3. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344(23):1743-9.
4. Baker V, Rone H, et al. Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization. Am J Obstet Gynecol. 2006;194(6):1668-74. discussion 1674-1665.
5. Bussen S, Steck T, et al. Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in-vitro fertilization failure. Hum Reprod. 2000;15(3):545-8.
6. Canaris G, Manowitz N, et al. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34.
7. Davis LB, Lathi RB, et al. The effect of infertility medication on thyroid function in hypothyroid women who conceive. Thyroid. 2007;17(8):773-7.
8. De Groot L, Abalovich M, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543-65.
9. Effraimidis G, Strieder TG, et al. Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur J Endocrinol. 2011;164(1):107-13.
10. Escudero F, Gonzales GF, et al. Hormone profile during the menstrual cycle at high altitude. Int J Gynaecol Obstet. 1996;55(1):49-58.
11. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 1997;18(3):404-33.
12. Glinoer D, de Nayer P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71(2):276-87.
13. Goldsmith RE, Sturgis SH, et al. The menstrual pattern in thyroid disease. J Clin Endocrinol Metab. 1952;12(7):846-55.
14. Gracia CR, Morse CB, et al. Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization. Fertil Steril. 2012;97(3):585-91.
15. Hofler M, Pfister H, et al. The use of weights to account for non-response and drop-out. Soc Psychiatry Psychiatr Epidemiol. 2005;40(4):291-9.
16. Hollowell JG, Staehling NW, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99.
17. Kilic S, Tasdemir N, et al. The effect of anti-thyroid antibodies on endometrial volume, embryo grade and IVF outcome. Gynecol Endocrinol. 2008;24(11):649-55.
18. Mandel SJ, Spencer CA, et al. Are detection and treatment of thyroid insufficiency in pregnancy feasible? Thyroid. 2005;15(1):44-53.
19. Mebis L, Van den Berghe G. Thyroid axis function and dysfunction in critical illness. Best Pract Res Clin Endocrinol Metab. 2011;25(5):745-57.
20. Mintziori G, Goulis DG, et al. "Thyroid function during ovarian stimulation: a systematic review." Fertil Steril. 2011.
21. Muller AF, Verhoeff A, et al. Decrease of free thyroxine levels after controlled ovarian hyperstimulation. J Clin Endocrinol Metab. 2000;85(2):545-8.
22. Negro R, Formoso G, et al. Euthyroid women with autoimmune disease undergoing assisted reproduction technologies: the role of autoimmunity and thyroid function. J Endocrinol Invest. 2007;30(1):3-8.
23. Negro R, Mangieri T, et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod. 2005;20(6):1529-33.
24. Poppe K, Glinoer D. Thyroid autoimmunity and hypothyroidism before and during pregnancy. Hum Reprod Update. 2003;9(2):149-61.
25. Poppe K, Unuane D, et al. Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome. Fertil Steril. 2011;96(1):241-5.
26. Poppe K, Velkeniers B, et al. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab. 2008;4(7):394-405.
27. Reh A, Grifo J, et al. "What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization." Fertil Steril. 2010.
28. Revelli A, Casano S, et al. A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments. Reprod Biol Endocrinol. 2009;7:137.
29. Rubin D. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.
30. Stuckey BG, Yeap D, et al. "Thyroxine replacement during super-ovulation for in vitro fertilization: a potential gap in management?" Fertil Steril. 2010 93(7): 2414 e2411-13.